MedArrive, a healthcare platform that enables payers and providers to extend medical services into the home, raised $25 million in Series A funding. Since the company’s founding in December 2020, MedArrive said it has doubled the size of its team, expanded into new states and facilitated thousands of home visits. Section 32 led the round with participation from new investors, 7wireVentures and Leaps by Bayer, and existing investors Define Ventures, Kleiner Perkins, and Redesign Health. The new financing will advance MedArrive’s underlying technology platform and fuel expansion of its network to meet demand for affordable, in-home care. Read more.
Related Posts
Vytalize Raises $100M in Extended Series B
Enhanced Healthcare Partners and Monroe Capital led, with North Coast Ventures participating.
February 22, 2023
MediGO Receives National Kidney Foundation Innovation Fund Investment
Launched in 2021, the NKF Innovation Fund works to accelerate funding, development, and commercialization of therapies that kidney patients need and deserve. The fund invests in early to mid-stage companies that are developing innovative, patient-centric kidney therapies.
December 21, 2022
Brightspring Registers IPO
Brightspring is a home and community-based healthcare services platform.
October 19, 2021